Conversely, GLP-1 receptor agonists inhibit AgRP/NPY neurons through a mechanism involving enhanced presynaptic GABAergic input mediated by both TRPC5 and K_ATP channels, and an indirect suppression of excitatory glutamatergic input via polysynaptic circuits [11]
While originally developed for blood sugar management, GLP-1 and GIP therapies are now commonly used under medical supervision to support metabolic health, weight management, and body composition in individuals who meet appropriate criteria
The study did not establish causation, but the event illustrates why small trials cannot be described as proof of safety
Motivation & Mental Tools 02:10:12 Mechanical & Behavioral Interventions, Emotional Regulation 02:15:52 Tool: Stop Intrusive Voices
The reduction held across every substance studied
Retatrutide Side Effects: What the Trials Reported Almost everything known about retatrutide's side-effect profile comes from two phase 2 trials